Colonoscopy: As easy as swallowing a pill
Colonoscopies are secure and have
been proven to be a successful way to screen for colon cancer. In any case, a
few patients cannot endure the procedure, or may be at higher risk for
sedation. During a standard colonoscope, a flexible tube (colonoscope) is
embedded into the rectum and guided by a physician through the colon. A camera
at the end of the colonoscope allows for visualization of polyps which, in case
left in place, can turn into cancer. The polyps are evacuated during the
procedure. Patients are sedated and require to take a day off from their normal
activities.
A new non-invasive and most recent alternative to this has been
developed in which the system can help distinguish growths called polyps, like
a colonoscopy. The patient ingests PillCam Colon 2, a capsule containing two
miniature cameras on the either end. It captures pictures as the capsule
descends the digestive tract and wirelessly transmits them to a recorder which
the patient wears on a belt. It is also used to detect inflammatory bowel
disease (Crohn’s disease), ulcers, and tumors of the small intestine. Introducing
the new structure, the patient has to gulp the capsule with water after which
the non-reusable capsule is excreted, it's flushed down the toilet. The patient
returns the recorder to the physician's office. In case a polyp is found, the
patient arranges to experience a colonoscopy to evacuate the growth.
A patient who undergoes the capsule technique has
to go through the same bowel-cleansing activity as a patient undergoing a
colonoscopy. But unlike a standard colonoscopy, the pill capsule system is
painless and requires no anaesthesia. Patients do not have to take a day off
work or arrange someone to drive them to and from the test. Colorectal
cancer is the most common cancer of the digestive organs, for over 60% of all
digestive organ cancers. It is the third-leading cause of cancer deaths in women and second
leading cause in men. Early detection and screening are essential to lessen the
rates of colorectal cancer. Primary detection has been confirmed to save
lives, in addition to the video capsule system also offers an appropriate
screening test for people who are unable to have a complete colonoscopy.
17th International Conference on Gastroenterology
and Hepatology provides an unparalleled platform for young minds and researchers to
talk over latest technology and research, which is slated on September 03-04,
2018 in Dubai, UAE.
For more details, visit the below link:
https://gastrocongress.conferenceseries.com/
Contact:
Anna
Harper
Program
Manager
World
Gastroenterology 2018
Email: hepatologymeet@gastroconferences.com
Comments
Post a Comment